28 related articles for article (PubMed ID: 23078874)
1. Guidelines for the labelling of leucocytes with (99m)Tc-HMPAO. Inflammation/Infection Taskgroup of the European Association of Nuclear Medicine.
de Vries EF; Roca M; Jamar F; Israel O; Signore A
Eur J Nucl Med Mol Imaging; 2010 Apr; 37(4):842-8. PubMed ID: 20198473
[TBL] [Abstract][Full Text] [Related]
2.
Guzmán Ortiz S; de la Torre Fernández S; Seva Delgado AE; Hernández Heredia CM
Rev Esp Med Nucl Imagen Mol (Engl Ed); 2023; 42(6):422-423. PubMed ID: 37748686
[No Abstract] [Full Text] [Related]
3. Validation of orthopedic allograft preparation process: a new application of media fill test.
Ossato A; Gasperoni C; Stella M; Montagner G; Trojan D; Giovagnoni G; Giannini M; Realdon F; Mezzadrelli V; Realdon N; Zuppini T; Tessari R
Cell Tissue Bank; 2024 Jun; 25(2):521-528. PubMed ID: 37728671
[TBL] [Abstract][Full Text] [Related]
4. Determination of brain death using
Günther A; Werner A; Fritzenwanger M; Brauer M; Freesmeyer M; Schulze PC; Salih F; Drescher R
Neurol Res Pract; 2024 Jan; 6(1):6. PubMed ID: 38268033
[No Abstract] [Full Text] [Related]
5. Implementation and validation of an in-house combined fluorescein/media-fill test to qualify radiopharmacy operators.
Fersing C; Deshayes E; Langlet S; Calas L; Lisowski V; Kotzki PO
EJNMMI Radiopharm Chem; 2021 Jan; 6(1):2. PubMed ID: 33411035
[TBL] [Abstract][Full Text] [Related]
6. A review of methods of separating and radiolabelling human leucocytes.
Danpure HJ; Osman S
Nucl Med Commun; 1988 Oct; 9(10):681-5. PubMed ID: 3062505
[No Abstract] [Full Text] [Related]
7. Development and testing of a new disposable sterile device for labelling white blood cells.
Signore A; Glaudemans AW; Malviya G; Lazzeri E; Prandini N; Viglietti AL; De Vries EF; Dierckx RA
Q J Nucl Med Mol Imaging; 2012 Aug; 56(4):400-8. PubMed ID: 23013669
[TBL] [Abstract][Full Text] [Related]
8. An in vitro study to compare 99mTc-stannous colloids and 99mTc-HMPAO for labelling human leukocytes.
Capriotti G; D'Alessandria C; Garin E; Weber E; Devillers A; Lehmann K; Corsetti F; Lecloirec J; Meller J; Becker W; Moisan A; Signore A
Q J Nucl Med Mol Imaging; 2004 Sep; 48(3):229-36. PubMed ID: 15499297
[TBL] [Abstract][Full Text] [Related]
9. New synthesis route of active substance d,l-HMPAO for preparation Technetium Tc99m Exametazime.
Pijarowska-Kruszyna J; Karczmarczyk U; Jaroń AW; Laszuk E; Radzik M; Garnuszek P; Mikołajczak R
Nucl Med Rev Cent East Eur; 2017; 20(2):88-94. PubMed ID: 28555448
[TBL] [Abstract][Full Text] [Related]
10. Validation of the leukocyte labeling procedure with a new kit for the preparation of technetium-99m exametazime injection.
Martinez T; Gallego Peinado M; Sanchez Catalicio J; Perez Angel F; Contreras Gutiérrez J
Nucl Med Commun; 2016 Apr; 37(4):432-4. PubMed ID: 26657217
[TBL] [Abstract][Full Text] [Related]
11. 99mTc-HMPAO labelling inhibits cell motility and cell proliferation and induces apoptosis of NC-NC cells.
Ulker O; Genç S; Ateş H; Durak H; Atabey N
Mutat Res; 2007 Jul; 631(2):69-76. PubMed ID: 17512775
[TBL] [Abstract][Full Text] [Related]
12. Media Fill Test for validation of autologous leukocytes separation and labelling by (99m)Tc-HmPAO.
Urbano N; Modoni S; Schillaci O
Nucl Med Biol; 2013 Jan; 40(1):104-8. PubMed ID: 23078874
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
